Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirapex ER Dosing Frequency in Parkinson's Disease
NCT01515774Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pramipexole in Parkinson's disease (PD), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01515774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515774.